(Q40618207)

https://api.crossref.org/works/10.1128/AAC.13.3.479

22 September 2017

Activity of flumequine against Escherichia coli: in vitro comparison with nalidixic and oxolinic acids (English)

1 reference

28 June 2022

1 reference

https://api.crossref.org/works/10.1128/AAC.13.3.479

28 June 2022

Escherichia coli

object named as

Escherichia coli

1 reference

D. Greenwood

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A400825

28 June 2022

language of work or name

English

0 references

publication date

1 March 1978

1 reference

PMC publication ID

352267

full work available at URL

22 September 2017

https://europepmc.org/articles/PMC352267

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A400825

https://europepmc.org/articles/PMC352267?pdf=render

28 June 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A400825

https://journals.asm.org/doi/pdf/10.1128/AAC.13.3.479

28 June 2022

1 reference

https://api.crossref.org/works/10.1128/AAC.13.3.479

Antimicrobial Agents and Chemotherapy

28 June 2022

published in

1 reference

22 September 2017

13

1 reference

22 September 2017

3

1 reference

22 September 2017

479-483

1 reference

Treatment of "bacterial cystitis" in fully automatic machanical models simulating conditions of bacterial growth in the urinary bladder

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352267

Bioevaluation of the antibacterial flumequine for urinary tract use

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352267

Factors influencing the response of Escherichia coli to antibiotics in conditions prevailing in the infected urinary bladder

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352267

Differentiation of mechanisms responsible for inoculum effects in the response of Escherichia coli to a variety of antibiotics

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352267

In Vitro Susceptibility Comparisons and Recommendations for Oxolinic Acid

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352267

Factors Governing the Emergence of Resistance to Nalidixic Acid in Treatment of Urinary Tract Infection

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352267

A Critical Evaluation of Nalidixic Acid in Urinary-Tract Infections

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352267

Nalidixic acid and oxolinic acid in the treatment of chronic bacteriuria.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352267

Some effects of subinhibitory concentrations of antibiotics on bacteria

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352267

Resistance to nalidixic acid. A misconception due to underdosage.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352267

NALIDIXIC ACID IN INFECTIONS OF URINARY TRACT. LABORATORY AND CLINICAL INVESTIGATIONS.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352267

Emergence of resistant organisms as a function of dose in oxolinic acid therapy

20 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/400825

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparison of the Responses of Escherichia coli and Proteus mirabilis to Seven -Lactam Antibiotics

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/400825

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A twelve channel bacterial growth monitoring system

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/400825

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.13.3.479

1 reference

22 September 2017

1 reference

PMC publication ID

352267

22 September 2017

1 reference

PMC publication ID

352267